New England BioLabs, Inc. (NEB) is a privately held company, headquartered in Ipswich, MA, and is a global leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research. NEB now offers the largest selection of recombinant and native enzymes for genomic research and continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. NEB is also focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development.